Table 1.
Paired-label biodistribution of L8A4 labeled with 177Lu using 1B4M-DTPA and with 125I using SGMIB in athymic mice with subcutaneous U87MG. EGFR human glioma xenografts
| Nuclide | Tissue | Day 1 | Day 4 | Day 8 |
|---|---|---|---|---|
| 177Lu | Blood | 19.78 ± 2.94 | 10.75 ± 2.88 | 1.35 ± 0.94 |
| Liver | 8.36 ± 0.74 | 7.52 ± 2.18 | 4.16 ± 0.54 | |
| Spleen | 5.64 ± 1.13 | 4.62 ± 1.73 | 2.01 ± 1.01 | |
| Kidneys | 8.06 ± 1.03 | 5.34 ± 1.25 | 2.61 ± 0.32 | |
| Lung | 6.87 ± 1.61 | 6.00 ± 3.12 | 0.93 ± 0.45 | |
| Bone | 3.58 ± 1.44 | 2.44 ± 0.71 | 1.82 ± 0.52 | |
| Muscle | 1.64 ± 0.08 | 0.88 ± 0.22 | 0.30 ± 0.07 | |
| Brain | 0.58 ± 0.13 | 0.40 ± 0.12 | 0.07 ± 0.05 | |
| Thyroida | 0.50 ± 0.13 | 0.27 ± 0.07 | 0.11 ± 0.04 | |
| Tumor | 31.58 ± 7.24 | 29.24 ± 6.03 | 15.27 ± 5.16 | |
| 125I | Blood | 18.78 ± 2.24 | 10.64 ± 2.86 | 1.29 ± 0.87 |
| Liver | 5.11 ± 0.86 | 2.89 ± 0.75 | 0.42 ± 0.32 | |
| Spleen | 4.48 ± 0.72 | 2.26 ± 0.80 | 0.28 ± 0.19 | |
| Kidneys | 4.73 ± 0.68 | 2.74 ± 0.69 | 0.39 ± 0.29 | |
| Lung | 6.81 ± 1.40 | 4.28 ± 0.78 | 0.58 ± 0.41 | |
| Bone | 3.02 ± 0.99 | 1.53 ± 0.49 | 0.33 ± 0.18 | |
| Muscle | 1.66 ± 0.08 | 0.85 ± 0.19 | 0.15 ± 0.10 | |
| Brain | 0.55 ± 0.13 | 0.40 ± 0.10 | 0.05 ± 0.04 | |
| Thyroida | 0.37 ± 0.30 | 0.31 ± 0.07 | 0.02 ± 0.03 | |
| Tumor | 21.64 ± 4.53 | 9.60 ± 1.72 | 2.86 ± 0.98 |
Values presented as percent injected dose per gram tissue (% ID/g), mean ″ standard deviation; five mice per group.
Percent injected dose in the thyroid.